
Desipramine is a tricyclic antidepressant used in veterinary medicine to manage anxiety-related behavioral disorders such as separation anxiety, compulsive behaviors, and fear-based reactions in dogs and cats. It is also prescribed for urinary incontinence in dogs by increasing urethral sphincter tone.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider desipramine for patients presented with chronic anxiety, specific types of compulsive behaviors or localized nerve-related discomfort. It is frequently a point of discussion for canine and feline patients where other behavioral modification strategies or medications have been evaluated. In some clinical contexts, veterinarians may discuss desipramine in the management of cataplexy or narcolepsy, though professional guidance on these specific applications remains specialized.
At a pharmacological level, desipramine acts as a potent inhibitor of the reuptake of norepinephrine within the central nervous system. By blocking the reabsorption of This neurotransmitter into the presynaptic neuron, the medication increases the concentration of norepinephrine available in the synaptic cleft. desipramine is characterized by its high selectivity for the norepinephrine transporter, having a relatively lower influence on the serotonin system. This mechanism allows for the modulation of mood, arousal and the transmission of specific signals associated with chronic stress or discomfort. Your veterinarian will determine the clinical appropriateness of desipramine based on your pet’s behavioral history, health status and the nature of the reactive state being addressed.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of desipramine include mild sedation, localized digestive changes such as vomiting or a temporary decrease in appetite. Because it possesses anticholinergic properties, some animals may exhibit behavioral shifts including dry mouth, temporary coordination changes or a decrease in tear production (keratoconjunctivitis sicca). Owners should monitor their pet for any unusual behavioral shifts, significant changes in energy levels or changes in heart rhythm and contact their veterinarian promptly with any concerns.
This medication is typically used with extra caution or avoided in patients with known cardiovascular disease, glaucoma, prostatic hypertrophy or a history of seizures. It is also carefully evaluated in pets with pre-existing hepatic or renal impairment, as these organs are involved in the metabolism and excretion of the medication. Significant interactions can occur if desipramine is administered concurrently with MAOIs, other serotonergic agents or central nervous system depressants. It is important to never discontinue this medication abruptly; your veterinarian is the right person to provide guidance on the necessary duration of use and the proper tapering schedule to ensure the management approach remains suitable for your pet's needs.
Yes. Desipramine is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all veterinarian-client-patient relationships before any medication is prepared or shipped to your home.
Yes. While desipramine is available in various commercial tablet formats for humans, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or smaller capsules—to suit the specific needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians most commonly discuss desipramine for the management of chronic anxiety, compulsive behaviors and certain types of nerve-related discomfort. Its mechanism acts to manage the levels of norepinephrine in the brain, providing a method for modulating mood and reactive states.
Veterinarians often discuss that it can take several weeks of consistent administration before the full physiological influence of a tricyclic antidepressant is observed. Your veterinarian will provide guidance on the expected timeline and what progress indicators to monitor during the management course.
Mild sedation is a commonly observed effect of desipramine, particularly when first starting the medication. While some pets may appear more relaxed or lethargic, your veterinarian will monitor the degree of sedation to ensure it remains within a safe and appropriate range for your pet’s needs.